Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.
It has been widely debated whether class IIa HDACs have catalytic deacetylase activity, and whether this plays any part in controlling gene expression. Herein, it has been demonstrated that class IIa HDACs isolated from mammalian cells are contaminated with other deacetylases, but can be prepared cleanly in Escherichia coli. These bacteria preparations have weak but measurable deacetylase activity. The low efficiency can be restored either by: mutation of an active site histidine to tyrosine, or by the use of a non-acetylated lysine substrate, allowing the development of assays to identify class IIa HDAC inhibitors.
Jones
Philip
P
IRBM/Merck Research Laboratories, Via Pontina km 30,600, 00040 Pomezia, Italy. philip_jones@merck.com
Altamura
Sergio
S
De Francesco
Raffaele
R
Gallinari
Paola
P
Lahm
Armin
A
Neddermann
Petra
P
Rowley
Michael
M
Serafini
Sergio
S
Steinkühler
Christian
C
D000107:Acetylation; D001549:Benzamides / Q000494:pharmacology; D002384:Catalysis; D002478:Cells, Cultured; D004926:Escherichia coli / Q000201:enzymology; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000145:classification / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D007668:Kidney / Q000201:enzymology; D015394:Molecular Structure; D009154:Mutation; D010456:Peptides, Cyclic / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013449:Sulfonamides
D001549:Benzamides; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C477361:LAQ824; D010456:Peptides, Cyclic; D011725:Pyridines; D011743:Pyrimidines; D013449:Sulfonamides; C102351:apicidin; C118739:entinostat; C523184:mocetinostat; D006655:Histone Deacetylases; C487081:belinostat